Lee Seokjoo, Dohlman Thomas H, Dana Reza
Laboratory of Ocular Immunology, Transplantation, and Regeneration, Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Laboratory of Ocular Immunology, Transplantation, and Regeneration, Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Transplant Rev (Orlando). 2025 Apr;39(2):100909. doi: 10.1016/j.trre.2025.100909. Epub 2025 Jan 9.
Immunology depends on maintaining a delicate balance within the human body, and disruptions can result in conditions such as autoimmune diseases, immunodeficiencies, and hypersensitivity reactions. This balance is especially crucial in transplantation immunology, where one of the primary challenges is preventing graft rejection. Such rejection can lead to organ failure, increased patient mortality, and higher healthcare costs due to the limited availability of donor tissues relative to patient needs. Xenotransplantation, like using porcine corneas for human transplants, offers a potential solution to the donor tissue shortage but faces substantial immunological rejection issues. To prevent rejection in both allo- and xenotransplantation, a deep understanding of how the body maintains immunological balance is essential, particularly since achieving tolerance to non-self tissues is considered the "holy grail" of the field. The cornea, the most frequently transplanted solid organ, has a high acceptance rate due to its immune-privileged status and serves as an ideal model for studying graft rejection mechanisms that disrupt tolerance. However, multiple immune pathways complicate our understanding of these mechanisms. This review examines the rejection mechanisms in corneal transplantation, identifying key cells involved and potential therapeutic strategies to induce and maintain immunological tolerance in both allo- and xenografts across various transplants.
免疫学依赖于在人体内维持微妙的平衡,而这种平衡的破坏可能导致自身免疫性疾病、免疫缺陷和超敏反应等病症。这种平衡在移植免疫学中尤为关键,其中一个主要挑战是防止移植物排斥。由于相对于患者需求而言供体组织的可用性有限,这种排斥可能导致器官衰竭、患者死亡率增加以及更高的医疗成本。异种移植,如使用猪角膜进行人体移植,为供体组织短缺提供了一种潜在的解决方案,但面临着严重的免疫排斥问题。为了在同种异体移植和异种移植中防止排斥,深入了解人体如何维持免疫平衡至关重要,特别是因为实现对非自身组织的耐受性被认为是该领域的“圣杯”。角膜是最常移植的实体器官,因其免疫赦免状态而具有很高的接受率,是研究破坏耐受性的移植物排斥机制的理想模型。然而,多种免疫途径使我们对这些机制的理解变得复杂。本综述探讨了角膜移植中的排斥机制,确定了涉及的关键细胞以及在各种移植中诱导和维持同种异体和异种移植物免疫耐受性的潜在治疗策略。